| 0.9 0.209 (30.25%) | 09-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.2 |
1-year : | 1.4 |
| Resists | First : | 1.02 |
Second : | 1.2 |
| Pivot price | 0.76 |
|||
| Supports | First : | 0.81 |
Second : | 0.68 |
| MAs | MA(5) : | 0.76 |
MA(20) : | 0.78 |
| MA(100) : | 1.29  |
MA(250) : | 1.53 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 27.4 |
D(3) : | 16.4 |
| RSI | RSI(14): 53.2 |
|||
| 52-week | High : | 2.5 | Low : | 0.68 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AHG ] has closed It is unclear right now based on current values. 54.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.03 - 1.04 | 1.04 - 1.05 |
| Low: | 0.72 - 0.73 | 0.73 - 0.73 |
| Close: | 0.89 - 0.9 | 0.9 - 0.91 |
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Thu, 10 Sep 2026
Akso (AHG) Slides Another -6.99% — Relief Rally Falters 2026-09-10 - RSI Overbought Alerts - dars.gov.et
Fri, 04 Sep 2026
Akso Health Group ADS (AHG) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Wed, 02 Sep 2026
Akso Health Group ADS (AHG) Key Financial Ratios – Valuation, Profitability & More - Value Research
Mon, 31 Aug 2026
Akso Health Group ADS (AHG) Peer Comparison – Compare with Others - Value Research
Fri, 28 Aug 2026
Akso Health Group (AHG) Slides 6% to $0.92 as Support Looms at $0.87 - Liquidity Order Flow - dars.gov.et
Mon, 03 Aug 2026
Akso Health Group (AHG) Tumbles 8.3% to $1.44, Testing Key Support at $1.37 - Defined Outcome ETF - dars.gov.et
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 854 (M) |
| Shares Float | 854 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 20 (K) |
| Shares Short P.Month | 19 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | -135 % |
| Operating Margin | -37.5 % |
| Return on Assets (ttm) | -1.3 % |
| Return on Equity (ttm) | -9.9 % |
| Qtrly Rev. Growth | -12.9 % |
| Gross Profit (p.s.) | -0.01 |
| Sales Per Share | 0.01 |
| EBITDA (p.s.) | -0.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -351 (M) |
| PE Ratio | -30 |
| PEG Ratio | 0 |
| Price to Book value | 4.28 |
| Price to Sales | 55.57 |
| Price to Cash Flow | -60.1 |
| Dividend | 1.2 |
| Forward Dividend | 0 |
| Dividend Yield | 133.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|